The Malaria Synergy Program (MSP) brings together experts with complementary expertise into a multidisciplinary program to address major roadblocks to achieving the goals of malaria elimination in the Asia-Pacific region and globally.
Malaria is a major global health problem. Progress in reducing the global burden stalled in 2015 and the burden increased in 2020. The Malaria Synergy Program aims to generate new knowledge, tools, and strategies to overcome major roadblocks in malaria detection, treatment, and prevention to accelerate progress towards elimination of malaria caused by P. Falciparum and P. vivax.
2023–2028.
The Malaria Synergy Program investigators and our teams will focus on developing novel approaches to optimise drug treatment, achieving highly efficacious and long-lasting vaccines, and developing novel tools to map and discover drivers of malaria transmission.
Our 3 core themes are:
Plasmodium malariae is a neglected malaria parasite, overshadowed by P. falciparum and P. vivax. The symptoms from P. malariae infections are often mild or absent, necessitating sensitive and targeted screening to detect these infections. Using these methods, studies reveal increased prevalence of P. malariae in areas where other species have decreased. Despite this, P. malariae infection dynamics and relationship to other species remains poorly understood. With advanced sequencing techniques we aim to describe the epidemiology and infection dynamics of this understudied parasite. Understanding these patterns is crucial for ensuring that all species are targeted in ongoing malaria elimination efforts. Genotyping can help us form a detailed understanding of the genetic diversity and population structure of P. malariae. This information is essential for identifying transmission patterns, tracking how specific strains spread and if they cause chronic infections in individuals.
This project aims to characterise the genetic diversity of P. malaria populations in Papua New Guinea to measure transmission dynamics and validate markers for tracking infections over time and space. The results will contribute to the development of molecular tools for P. malariae surveillance to support malaria control efforts. This can inform more effective public health strategies and contribute to the global effort to control and eventually eliminate malaria of all species.
We will use samples from longitudinal studies in Papua New Guinea collected between 2004 and 2024. Samples will undergo targeted genotyping and whole genome sequencing to identify genetic markers of P. malariae and map transmission dynamics. Genotyping will distinguish new from redetected infections to estimate longevity and mapping. Whole genome sequencing of a subset of samples will validate the marker panel and identify genes under selection such as drug resistance markers.
2
Within-host infection complexity is a poorly understood aspect of malaria genomic epidemiology and is particularly important as malaria parasites require multi-clone infections to generate diversity through sexual recombination. As transmission declines, there are fewer infections overall, and this reduces infection complexity, but there is a complex relationship with other environmental factors that we don’t fully understand.
Defining the parameters of transmission dynamics is critical for malaria control programs to assess their efficacy and progress towards malaria elimination. Insights into within-host infection complexity and genetic diversity will also shed light on the processes by which malaria parasites adapt to changing transmission, as well as the potential for the emergence and spread of advantageous traits such as drug resistance or virulence.
The aim of this project is to determine the relationship between complexity of infection and malaria transmission for P. falciparum, the most virulent human malaria parasites. The project will use DNA sequencing data available for samples collected from serial cross-sectional sectional surveys conducted in Papua New Guinea from 2005 to 2020 to measure infection complexity over time and space in context with transmission.
Analysis of infection complexity and clonal variants in deep sequencing data will explore how changes in malaria transmission due to malaria control impacts the diversity of clones within infections at the individual and population level. Data on infecting clones from these cross-sectional studies will also help to calibrate analysis algorithms for other less diverse genetic markers used for measuring drug resistance and transmission dynamics.
Tackling malaria in the Asia-Pacific region involves a number of key challenges related to increasingly heterogeneous malaria transmission, the presence of a large reservoir of infected but asymptomatic individuals, and the development of drug resistance. The predominance of Plasmodium vivax infections also poses the challenge of relapsing malaria caused by P. vivax hypnozoites (dormant parasites). Epidemiological and surveillance programs in Papua New Guinea over almost two decades have resulted in a large sample set covering a period of transmission decline and resurgence. An understanding of how malaria control efforts impact the parasite population, and identifying possible causes of resurgence is crucial to eliminating malaria.
Through genomic analysis of Plasmodium vivax isolates collected in Papua New Guinea, this project aims to:
The project uses custom next generation sequencing assays and bioinformatic approaches for analysing human malaria samples including population genetics and statistical analyses. Working in the context of a large multidisciplinary team, and extensive collaborative network, the genomic data will be further combined with other epidemiological data on malaria risk and exposure to investigate spatio-temporal determinants of malaria, and to develop new approaches for improved surveillance.
Malaria genomic surveillance is crucial to understand how control strategies can lead to elimination. The classification of transmission dynamics and tracking lineages over time and space can aid in malaria elimination. In Papua New Guinea there have been extensive control measures since 2006 including vector control, rapid diagnostic testing, and highly effective treatment, which initially resulted in a substantial decline in parasite prevalence.
Recently, parallel rebounds in transmission and the emergence of an artemisinin resistant lineage has been observed raising questions about what might be driving the resurgence. Population genetic analysis of P. falciparum isolates collected from Madang and East Sepik provinces at 8 time points between 2005 and 2020 identified persistent lineages that appear to have expanded during low transmission.
We have also identified a recently emerged lineage from Madang 2020 which includes drug resistant strains. Using whole genome sequencing of isolates from these lineages this project will:
2
National Health and Medical Research Council (NHMRC)